Open AccessINFLIXIMAB AS A FIRST-LINE THERAPY IN NEWLY DIAGNOSED CROHN??S DISEASE (CD) PROMOTES LONG-TERM SUSTAINED REMISSION AND ALTERS THE COURSE OF THE DISEASE
Author(s) -
C. Bascietto,
Luciana De Angelis,
Osvaldo Borrelli,
Barbara Bizzarri,
Fabiola Fornaroli,
Franca Viola,
M. Cirulli,
Salvatore Cucchiara
Publication year - 2005
Publication title -
journal of pediatric gastroenterology and nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.206
H-Index - 131
eISSN - 1536-4801
pISSN - 0277-2116
DOI - 10.1097/00005176-200505000-00103
Subject(s) - medicine , infliximab , azathioprine , maintenance therapy , methotrexate , crohn's disease , gastroenterology , surgery , disease , chemotherapy